Immune tolerance in multiple sclerosis
نویسندگان
چکیده
منابع مشابه
Immune Rebound: Multiple Sclerosis after Treatment of Cushing’s disease
High cortisol level in endogenous Cushing’s syndrome suppresses the immune system and after treatment there may be an over activity of immune reaction leading to autoimmune diseases mostly thyroid and rheumatologic disorders. This is the second reported case of multiple sclerosis developing after treatment of Cushing’s syndrome. A 42-year old man is reported who presented with bone fracture and...
متن کاملMultiple Sclerosis in Iran
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS). This highlydisabling disorder is characterized by a variable clinical course. MS is a heterogeneous disease with acomplex pathology and significant social and economic impact. MS is associated with dysfunction ofparts of the nervous system which results in a range of signs and symptoms, ...
متن کاملImmunotherapy in Multiple Sclerosis (Ms)
Summary The immunosuppressive agent has changed the clinical course of MS. Mostly,this agent, like cyclophosphamide cyclosporine A., and X-Ray of the lymphoid organ, has a lot of side effects. It should only be used in the most severe from of MS among immunosuppressive agents, Azathioprin has been used most frequently in spite of the fact that it is not very effective compared with other immun...
متن کاملMultiple sclerosis and immune regulatory cells.
The multiple sclerosis disease process is defined on the basis of lesions disseminated in space and time within the CNS. Immunization of humans (vaccines) and animals with neural tissue can result in multi-focal CNS inflammatory lesions with demyelination; such disorders are usually uniphasic or selflimited. They are initiated by systemically activated myelinreactive T cells that then access th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Immunological Reviews
سال: 2011
ISSN: 0105-2896
DOI: 10.1111/j.1600-065x.2011.01016.x